Dexcom’s G7 is in front of the FDA right now. There are some significant changes to the system, including what’s basically a snooze for essential alarms, including the urgent low. Dexcom’s Chief Technology Officer Jake Leach answers your questions about adhesive, direct to watch, accuracy, and even mentions the G8. Here’s more information about the…
This week, we’re having a conversation about diabetes beyond numbers. Yes, there are a lot of those and they are very important. But have you ever stopped to think about the mental energy and emotional effort behind those numbers? Even if your A1C and Time in Range are what your doctor wants to see. Our…
We don’t need to tell you that the mental burden of diabetes is a heavy one. And most of us – caregivers and people with diabetes alike – are never given any resources to help. My guest this week is trying to help. Dr. Mark Heyman is a diabetes psychologist and lives with type 1…
It’s always a privilege to talk to one of the Joslin Medalists. This week you’ll hear from Laurie Harper. She was diagnosed as a toddler in 1955 and will mark 67 years with type 1 later this year. She shares what she remembers about her early years with diabetes, how her family adjusted, the technology…
There’s a new plan to manufacture and sell insulin at a much lower list price. The company behind it is non-profit Civica RX, which has support from JDRF. Stacey talks to JDRF CEO Aaron Kowalski about what their role is here, how realistic this plan is, who it may help and a lot more. They…
There’s been a lot of excitement recently about stem cell transplants and progress toward using this as a functional cure for type 1. There are a few separate groups working on this, this week we’re talking to ViaCyte to get past the hype and look at the real progress here. You’ll hear from ViaCyte’s Head…
In February, the FDA approved the Eversense E3 for 180 day wear. That means you could have a CGM working – with no sensor changes needed – for up to six months. That’s been available in Europe for a while, but in the US it’s been a maximum of three months. As you’ll hear, the…
Lauren Bongiorno was diagnosed with type 1 as a child and growing up, she showed every sign of success. She was a division one athlete, playing soccer in college and achieved the lowest A1C her endo had seen in a college student.. but while her care team celebrated that 5.7, she was miserable. Lauren shares…
Last fall, Sigi pump received Breakthrough Device Designation from the US FDA. Although it’s still a long way from being released, Sigi is very intriguing; it uses some of the best parts of existing pump systems. Pim Von Wesel is Co-CEO of AMF Medical, the company that makes the Sigi Pump. We’ll talk about what…
The US FDA has approved Insulet’s Omnipod 5 Automated Insulin Delivery System. This system was submitted more than a year ago but has been delayed due to COVID 19. Stacey talks to Dr. Trang Ly, Senior Vice President & Medical Director at Insulet Corporation who explains what makes this system different from the other AID…